Perineal talc use and ovarian cancer: A critical review

European Journal of Cancer Prevention

Volumn 17, Issue 2, 2008, Pages 139-146

  Muscat, Joshua E ^a,b   Huncharek, Michael S ^b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Asbestos; Bias; Epidemiology; Inflammation; Meta analysis; Mineralogy; Ovarian cancer; Pleurodesis; Talc

Indexed keywords

ANTINEOPLASTIC AGENT; ASBESTOS; LATEX; TALC;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CARCINOGENIC ACTIVITY; CARCINOGENICITY; CONDOM; CYTOREDUCTIVE SURGERY; ENVIRONMENTAL EXPOSURE; FEMALE GENITAL SYSTEM; HUMAN; NONHUMAN; OVARY CANCER; PERINEUM; PLEURA EFFUSION; PLEURODESIS; PNEUMOTHORAX; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TREATMENT OUTCOME;

ASBESTOS; CASE-CONTROL STUDIES; COSMETICS; DOSE-RESPONSE RELATIONSHIP, DRUG; DUST; FEMALE; HUMANS; OVARIAN NEOPLASMS; PERINEUM; RISK FACTORS; TALC;

EID: 39749091728     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32811080ef     Document Type: Review

References (70)

1. Anonymous (1979). Research Committee of the British Thoracic Association and the Medical Research Council Pneumoconiosis Unit. A survey of the longterm effects of talc and kaolin pleurodesis. Br J Dis Chest 73:285-288.
2. Anonymous (1982a). Study links talc use to ovarian cancer. In: Boston Globe 6 August 1982.
3. Anonymous (1982b). Talcum company calls study on cancer link inconclusive. In: New York Times, 12 August 1982.
4. Acheson ED, Gardner MJ, Pippard EC, Grime LP (1982). Mortality of two groups of women who manufactured gas masks from chrysotile and crocidolite asbestos: a 40-year follow-up. Br J Ind Med 39:344-348.
5. Antony VB (2003). Immunological mechanisms in pleural disease. Eur Respir J 21:539-544.
6. Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Cogliano V (2006). Carcinogenicity of carbon black, titanium dioxide, and talc. Lancet Oncol 7:295-296.
7. Bankhead CR, Kehoe ST, Austoker J (2005). Symptoms associated with diagnosis of ovarian cancer: a systematic review. BJOG 112:857-865.
8. Bankole A, Darroch JE, Singh S (1999). Determinants of trends in condom use in the United States, 1988-1995. Fam Plann Perspect 31:264-271.
9. Bonovas S, Filioussi K, Sitaras NM (2005). Do nonsteroidal anti-inflammatory drugs affect the risk of developing ovarian cancer? A meta-analysis. Br J Clin Pharmacol 60:194-203.
10. Boorman GA, Seely JC (1995). The lack of an ovarian effect of lifetime talc exposure in F344/N rats and B6C3F1 mice. Regul Toxicol Pharmacol 21:242-243.
11. Booth M, Beral V, Smith P (1989). Risk factors for ovarian cancer: a case-control study. Br J Cancer 60:592-598.
12. Castleman M (1980). A consumer's guide to the condom comeback. Med Self Care Summer:35-37.
13. Chang S, Risch HA (1997). Perineal talc exposure and risk of ovarian carcinoma. Cancer 79:2396-2401.
14. Chen Y, Wu PC, Lang JH, Ge WJ, Hartge P, Brinton LA (1992). Risk factors for epithelial ovarian cancer in Beijing, China. Int J Epidemiol 21:23-29.
15. Cook LS, Kamb ML, Weiss NS (1997). Perineal powder exposure and the risk of ovarian cancer. (see comment, erratum appears in Am J Epidemiol 1998 Aug 15;148(4):410). Am J Epidemiol 145:459-465.
16. Cramer DW, Liberman RF, Titus-Ernstoff L, Welch WR, Greenberg ER, Baron JA, Harlow BL (1999). Genital talc exposure and risk of ovarian cancer. Int J Cancer 81:351-356.
17. Cramer DW, Titus-Ernstoff L, McKolanis JR, Welch WR, Vitonis AF, Berkowitz RS, Finn OJ (2005). Conditions associated with antibodies against the tumor-associated antigen MUC1 and their relationship to risk for ovarian cancer. Cancer Epidemiol Biomarkers Prev 14:1125-1131.
18. Cramer DW, Welch WR, Scully RE, Wojciechowski CA (1982). Ovarian cancer and talc: a case-control study. Cancer 50:372-376.
19. Endocapron S, Renier A, Janson X, Kheuang L, Jaurand MC (1993). In vitro response of rat pleural mesothelial cells to talc samples in genotoxicity assays (sister chromatid exchanges and DNA-repair). Toxicol In vitro 7:7-14.
20. Ferrer J, Villarino MA, Tura JM, Traveria A, Light RW (2001). Talc preparations used for pleurodesis vary markedly from one preparation to another. Chest 119:1901-1905.
21. Gertig DM, Hunter DJ, Cramer DW, Colditz GA, Speizer FE, Willett WC, Hankinson SE (2000). Prospective study of talc use and ovarian cancer. J Natl Cancer Inst 92:249-452.
22. Glud E, Kjaer SK, Thomsen BL, Hogdall C, Christensen L, Hogdall E, et al. (2004). Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer. Arch Intern Med 164:2253-2259.
23. Godard B, Foulkes WD, Provencher D, Brunet JS, Tonin PN, Mes-Masson AM, et al. (1998). Risk factors for familial and sporadic ovarian cancer among French Canadians: a case-control study. Am J Obstet Gynecol 179:403-410.
24. Graham J, Graham R (1967). Ovarian cancer and asbestos. Environ Res 1:115-128.
25. Green A, Purdie D, Bain C, Siskind V, Russell P, Quinn M, Ward B (1997). Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer. Survey of Women's Health Study Group. Int J Cancer 71:948-951.
26. Gross AJ, Berg PH (1995). A meta-analytical approach examining the potential relationship between talc exposure and ovarian cancer. J Exposure Anal Environ Epidemiol 5:181-195.
27. Hankinson SE, Hunter DJ, Colditz GA, Willett WC, Stampfer MJ, Rosner B, et al. (1993). Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study. JAMA 270:2813-2818.
28. Harlow BL, Cramer DW, Bell DA, Welch WR (1992). Perineal exposure to talc and ovarian cancer risk. Obstet Gynecol 80:19-26.
29. Harlow BL, Weiss NS (1989). A case-control study of borderline ovarian tumors: the influence of perineal exposure to talc. Am J Epidemiol 130:390-394.
30. Heller DS, Gordon RE, Westhoff C, Gerber S (1996a). Asbestos exposure and ovarian fiber burden. Am J Ind Med 29:435-439.
31. Heller DS, Westhoff C, Gordon RE, Katz N (1996b). The relationship between perineal cosmetic talc usage and ovarian talc particle burden. Am J Obstet Gynecol 174:1507-1510.
32. Henderson WJ, Hamilton TC, Griffiths K (1979). Talc in normal and malignant ovarian tissue. Lancet 1:499.
33. Henderson WJ, Joslin CA, Turnbull AC, Griffiths K (1971). Talc and carcinoma of the ovary and cervix. J Obstet Gynaecol Br Commonwealth 78:266-272.
34. Honma N, Hiratsuka T, Kozawa E, Watanabe A, Saijo K, Shimizu K (1963). Clinical aspects of spontaneous pneumothorax. Origin and results of treatment in 70 cases. Chiryo 45:2169-2174.
35. Huncharek M (1986). The biomedical and epidemiological characteristics of asbestos-related diseases: a review. Yale J Biol Med 59:435-451.
36. Huncharek M, Geschwind JF, Kupelnick B (2003). Perineal application of cosmetic talc and risk of invasive epithelial ovarian cancer: a meta-analysis of 11,933 subjects from sixteen observational studies. Anticancer Res 23:1955-1960.
37. Huncharek M, Muscat JE, Onitilo A, Kupelnick BA (2007). Use of cosmetic talc on contraceptive diaphragms and risk of ovarian cancer: a meta-analysis of nine observational studies. Eur J Cancer Prev, in press.
38. Kasper CS, Chandler PJ Jr. (1995). Possible morbidity in women from talc on condoms. JAMA 273:846-847.
39. Kelly T, Matos G (2005). Historical statistics for mineral and material commodities in the United States. In: U.S. geological survey, vol. 2005 (available at http://purl.access.gpo.gov/GPO/LPS39957).
40. Krause J, Ashton W (1978). Misidentification of asbestos in talc. In: Gravatt CC, LaFleur PD, and United States. National Bureau of Standards, editors. Proceedings of a Workshop on Asbestos: Definitions and Measurement Methods: held at the National Bureau of Standards, Gaithersburg, Maryland, July 18-20, 1977. Washington: U.S. Dept. of Commerce, National Bureau of Standards. pp. 339-352.
41. Krause JB (1977). Mineralogical characterization of cosmetic talc products. J Toxicol Environ Health 2:1223-1226.
42. Krismann M, Pieper K, Muller KM (1998). Pleural reaction pattern after talc pleurodesis. Pathologe 19:214-220.
43. Lange P, Mortensen J, Groth S (1988). Lung function 22-35 years after treatment of idiopathic spontaneous pneumothorax with talc poudrage or simple drainage. Thorax 43:559-561.
44. Langseth H, Kjaerheim K (2004). Ovarian cancer and occupational exposure among pulp and paper employees in Norway. Scand J Work, Environ Health 30:356-361.
45. Mills PK, Riordan DG, Cress RD, Young HA (2004). Perineal talc exposure and epithelial ovarian cancer risk in the Central Valley of California. Int J Cancer 112:458-464.
46. Mossman BT, Gee JB (1989). Asbestos-related diseases. N Engl J Med 320:1721-1730.
47. Munnell EW (1952). Ovarian carcinoma; predisposing factors, diagnosis and management. Cancer 5:1128-1133.
48. Muscat J, Huncharek M, Cramer DW (2005). Talc and anti-MUC1 antibodies. Cancer Epidemiol Biomarkers Prev 14:2679 (author reply 2680).
49. Muscat JE, Barish M (1998). Epidemiology of talc exposure and ovarian cancer. A critical assessment. Comments Toxicol 6:327-335.
50. Nasreen N, Mohammed KA, Dowling PA, Ward MJ, Galffy G, Antony VB (2000). Talc induces apoptosis in human malignant mesothelioma cells in vitro. Am J Respir Crit Care Med 161:595-600.
51. Ness RB, Cottreau C (1999). Possible role of ovarian epithelial inflammation in ovarian cancer (see comment). J Natl Cancer Inst 91:1459-1467.
52. Ness RB, Grisso JA, Cottreau C, Klapper J, Vergona R, Wheeler JE, et al. (2000). Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer (see comment). Epidemiology 11:111-117.
53. Newhouse ML, Berry G, Skidmore JW (1982). A mortality study of workers manufacturing friction materials with chrysotile asbestos. Ann Occup Hyg 26:899-909.
54. Parazzini F, La Vecchia C, Negri E, Moroni S, dal Pino D, Fedele L (1996). Pelvic inflammatory disease and risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev 5:667-669.
55. Piccinino LJ, Mosher WD (1998). Trends in contraceptive use in the United States: 1982-1995. Fam Plann Perspect 30:4-10, 46.
56. Purdie D, Green A, Bain C, Siskind V, Ward B, Hacker N, et al. (1995). Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case-control study. Survey of Women's Health Study Group. Int J Cancer 62:678-684.
57. Risch HA, Howe GR (1995). Pelvic inflammatory disease and the risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 4:447-451.
58. Risch HA, Marrett LD, Howe GR (1994). Parity, contraception, infertility, and the risk of epithelial ovarian cancer. Am J Epidemiol 140:585-597.
59. Rohl AN, Langer AM, Selikoff IJ, Tordini A, Klimentidis R, Bowes DR, Skinner DL (1976). Consumer talcums and powders: mineral and chemical characterization. J Toxicol Environ Health 2:255-284.
60. Rosenblatt KA, Mathews WA, Daling JR, Voigt LF, Malone K (1998). Characteristics of women who use perineal powders. Obstet Gynecol 92:753-756.
61. Shaw P, Agarwal R (2004). Pleurodesis for malignant pleural effusions. Cochrane Database of Systematic Rev Art. No.: CD002916. DOI: 10.1002/14651858.CD002916.pub2.
62. Sjosten AC, Ellis H, Edelstam GA (2004). Retrograde migration of glove powder in the human female genital tract. Hum Reprod 19:991-995.
63. Stanton MF, Layard M, Tegeris A, Miller E, May M, Morgan E, Smith A (1981). Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. J Natl Cancer Inst 67:965-975.
64. Stanton MF, Laynard M, Tegeris A, Miller E, May M, Kent E (1977). Carcinogenicity of fibrous glass: pleural response in the rat in relation to fiber dimension. J Natl Cancer Inst 58:587-603.
65. Tzonou A, Polychronopoulou A, Hsieh CC, Rebelakos A, Karakatsani A, Trichopoulos D (1993). Hair dyes, analgesics, tranquilizers and perineal talc application as risk factors for ovarian cancer. Int J Cancer 55:408-410.
66. Wagner JC, Berry G, Cooke TJ, Hill RJ, Pooley FD, Skidmore JW (1975). Animal experiments with talc. Inhaled Part 4 (Pt 2):647-654.
67. Wehner AP (2002). Cosmetic talc should not be listed as a carcinogen: comments on NTP's deliberations to list talc as a carcinogen. Regulat Toxicol Pharmacol 36:40-50.
68. Whittemore AS, Wu ML, Paffenbarger RS Jr, Sarles DL, Kampert JB, Grosser S, et al. (1988). Personal and environmental characteristics related to epithelial ovarian cancer. II. Exposures to talcum powder, tobacco, alcohol, and coffee. Am J Epidemiol 128:1228-1240.
69. Wignall BK, Fox AJ (1982). Mortality of female gas mask assemblers. Br J Ind Med 39:34-38.
70. Wong C, Hempling RE, Piver MS, Natarajan N, Mettlin CJ (1999). Perineal talc exposure and subsequent epithelial ovarian cancer: a case-control study. (see comment). Obstet Gynecol 93:372-376.